Oral anticoagulants and other cardiovascular drugs have demonstrated efficacy in reducing mortality in COPD and right-sided heart failure.
In children aged 6–35 months, vaccination with 2 doses of IIV4 can protect against influenza and reduces the frequency of severe outcomes.
A large-scale bibliometric analysis underscores a lack of sex-related reporting in biomedical research, despite efforts to include more women in health-based studies.
The FDA has approved Sunosi to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or OSA.
The FDA issued a warning letter to NutraPharma, for selling false and misleading products that claim to treat addiction and chronic pain.